CLINICAL_TRIALS
trial_result
· 2018-02-26
Clinical Trial Update: Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers
Summary
A completed clinical trial evaluated whether prescription of 5-alpha-reductase inhibitors is associated with higher-grade prostate cancers in men with benign pr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rennes University Hospital | Conditions: Benign Prostate Hyperplasia | Status: COMPLETED